* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, October 9, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    MSG Entertainment Takes Radio City Music Hall Into the Future With Introduction of Sphere Immersive Sound – Business Wire

    MSG Entertainment Transforms Radio City Music Hall with Cutting-Edge Sphere Immersive Sound Experience

    Israel’s Entertainment Industry Is Being Targeted by the Left in Hollywood and the Right at Home – The Wall Street Journal

    Inside the Fierce Clash Shaping Israel’s Entertainment Industry: Hollywood vs. Local Voices

    Offset Is Ready To Finalize Divorce With Cardi B for a Major Reason – Yahoo

    Offset Poised to Finalize Divorce from Cardi B for a Major Reason

    Beyond the Stage: 8 Performing Arts Centers Driving Entertainment and Education – Livability.com

    Beyond the Stage: 8 Performing Arts Centers Transforming Entertainment and Education

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

    Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Wisconsin Dairy Leads the Way with Cutting-Edge Technology Systems

    ENERCON and Biome collaborate for wind turbine noise reduction technology – Yahoo Finance

    ENERCON and Biome Join Forces to Revolutionize Wind Turbine Noise Reduction

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    Is Light-Speed Analog Computing the Future of Technology? – BIOENGINEER.ORG

    Could Light-Speed Analog Computing Transform the Future of Technology?

    ARM Institute opens technology project call to speed submarine manufacturing – The Robot Report

    ARM Institute Unveils Cutting-Edge Technology Project to Revolutionize Submarine Manufacturing

    Forget Cowbells. Cows Wear High-Tech Collars Now. – The New York Times

    Ditch the Cowbells: Discover the High-Tech Collars Transforming Cattle Care

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    MSG Entertainment Takes Radio City Music Hall Into the Future With Introduction of Sphere Immersive Sound – Business Wire

    MSG Entertainment Transforms Radio City Music Hall with Cutting-Edge Sphere Immersive Sound Experience

    Israel’s Entertainment Industry Is Being Targeted by the Left in Hollywood and the Right at Home – The Wall Street Journal

    Inside the Fierce Clash Shaping Israel’s Entertainment Industry: Hollywood vs. Local Voices

    Offset Is Ready To Finalize Divorce With Cardi B for a Major Reason – Yahoo

    Offset Poised to Finalize Divorce from Cardi B for a Major Reason

    Beyond the Stage: 8 Performing Arts Centers Driving Entertainment and Education – Livability.com

    Beyond the Stage: 8 Performing Arts Centers Transforming Entertainment and Education

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

    Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Wisconsin Dairy Leads the Way with Cutting-Edge Technology Systems

    ENERCON and Biome collaborate for wind turbine noise reduction technology – Yahoo Finance

    ENERCON and Biome Join Forces to Revolutionize Wind Turbine Noise Reduction

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    Is Light-Speed Analog Computing the Future of Technology? – BIOENGINEER.ORG

    Could Light-Speed Analog Computing Transform the Future of Technology?

    ARM Institute opens technology project call to speed submarine manufacturing – The Robot Report

    ARM Institute Unveils Cutting-Edge Technology Project to Revolutionize Submarine Manufacturing

    Forget Cowbells. Cows Wear High-Tech Collars Now. – The New York Times

    Ditch the Cowbells: Discover the High-Tech Collars Transforming Cattle Care

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Advisory Panel Votes Against Once-Weekly Insulin for T1D

May 26, 2024
in Health
Advisory Panel Votes Against Once-Weekly Insulin for T1D
Share on FacebookShare on Twitter

In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of the investigational once-weekly basal insulin analog icodec (Novo Nordisk) don’t outweigh the increased risk for hypoglycemia in people with type 1 diabetes. 

The May 24 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee was convened specifically to advise the FDA of the benefits versus risks of icodec in people with type 1 diabetes based on the results of ONWARDS-6, one of Novo Nordisk’s randomized clinical trials of icodec. 

Five other ONWARDS trials were conducted in people with type 2 diabetes. The FDA hasn’t publicly raised concerns about efficacy and safety seen in any of those trials. 

In the phase 3a ONWARDS-6, in which 290 patients were randomized to icodec and 292 patients to once-daily degludec (Tresiba), icodec was noninferior in improving A1c at 26 weeks. However, there was a significant increase in serious or severe hypoglycemia with icodec compared with degludec (4.66 vs 1.0 events per 100 patient-years; 14 events in nine patients versus three in three patients), with the greatest incidence in the icodec group on days 2-4 after injection. None of the events resulted in treatment discontinuation or study withdrawal. 

Novo Nordisk representatives presented several possible risk mitigation strategies for icodec, including limiting use to patients wearing a continuous glucose monitor (CGM), restricting use to people with low glycemic variability, avoiding use in those with a history of hypoglycemic unawareness, and/or using alternative dosing strategies such as reducing mealtime bolus insulin doses on days 2-4 after injection. 

Panel members discussed at length whether the potential advantages of once-weekly versus daily basal dosing, such as possible improved adherence and convenience, outweighed the increased risk of hypoglycemia and whether the mitigation strategies would be workable in the real world. Regardless of their vote, most panelists agreed that the company should conduct further trials to gather evidence for the proposed mitigation strategies and determine which patients with type 1 diabetes could benefit most from the drug. 

Need for Contingencies “Makes Me Nervous”

Committee chair Cecilia C. Low Wang, MD, professor of medicine at the University of Colorado Anschutz Medical Campus, voted no to the benefits of icodec outweighing the risks, explaining: “I struggled with the vote because I think adding more treatment options…is super important for my patients with diabetes, especially my patients with type 1 diabetes, because that’s kind of an under-investigated area right now…I’m concerned that approving icodec for use at this point with inadequate data might be a disincentive for further trials, which I think are needed to use it safely in type 1 diabetes.” 

Panel member Matthew T. Drake, MD, PhD, of the Division of Endocrinology at Mayo Clinic College of Medicine, Rochester, Minnesota, also voted no, noting that “when compared to the current gold-standard degludec, which has a good safety profile in my experience, and based on review of the data today, this was an incremental increase [in hypoglycemia].”

Moreover, “I am also concerned about the potential that this would need to be sort of approved with contingencies, specifically the need for CGM. So that makes me nervous. The patients who may be most likely to benefit from this in my clinical practice are unfortunately the ones who tend to be the least likely to actually monitor their blood sugars with some regularity.”

A New Paradigm for Insulin Administration

Rita R. Kalyani, MD, professor of medicine in the Division of Endocrinology, Diabetes, & Metabolism at Johns Hopkins University School of Medicine in Baltimore, Maryland, also cited the need for further studies of patient-reported outcomes, subgroups who would benefit the most, and optimal titration schedules. 

Nonetheless, she voted yes. “As a once-weekly insulin, icodec offers a new paradigm for insulin administration, which may reduce treatment burden and facilitate medication-taking behavior for some individuals with type 1 diabetes. On the other hand, bolus dose adjustment required to prevent hypoglycemia during days 2 to 4, and potentially to prevent hyperglycemia on days 5 to 7, may add to the treatment complexity.”

However, Kalyani said, “Overall given that the primary outcome for A1c efficacy has been demonstrated as noninferior to insulin degludec, risk mitigation strategies to prevent and identify hypoglycemia in a timely manner are available ideally through CGM or alternatively self-monitoring blood glucose, and that effective treatments for hypoglycemia are readily available, guided by the compelling need to offer people with diabetes another treatment option to choose from as part of patient-centered care, my vote is yes.”

Patient representative Paul Tibbits, Jr, a health policy and communications professional in Washington, DC, also voted yes but said the decision was “a significant struggle” and icodec “is only approvable with significant caveats.” 

Tibbits added, “I certainly want to help people with diabetes, but I also don’t want to hurt them. And I think this product has the potential to do both. So, I would put the onus on the FDA to work with the applicant to make sure that if this is approved there are as many guardrails as possible to make sure we don’t harm people with type 1 diabetes.”

Technology, When Possible, Is “First Choice”

Asked to comment, endocrinologist Anne L. Peters, MD, director of the University of Southern California Westside Center for Diabetes, Los Angeles, told Medscape Medical News that automated insulin delivery (AID) systems, which only use short-acting insulin, are her first choice of treatment for patients with type 1 diabetes — and even some with type 2 diabetes — who are able to access and use them “because we’re talking about a system that is infinitely adjustable versus a system that is infinitely not adjustable…It’s night-and-day different.”

However, she also said select patients with type 1 diabetes might benefit from a once-weekly basal insulin, particularly those not using an AID system who don’t reliably take their daily doses. “This would give them a baseline of insulin that could be helpful…There are so many times when I’m in type 1 clinic in [an under-resourced part of Los Angeles] that I wish I had a once-weekly insulin because it would keep people out of the hospital…It certainly isn’t for everybody, but then nothing is.” 

Insulin icodec was approved earlier this year in Canada, Switzerland, and the European Union for people with type 1 or type 2 diabetes.

Advisory panel members are vetted for disclosures and waivers granted for participation if needed, but none were required for this meeting. Peters has reported serving on advisory boards for Abbott Diabetes Care, Becton Dickinson, Boehringer Ingelheim, Eli Lilly, Lexicon Pharmaceuticals, Livongo, Medscape, Merck, Novo Nordisk, Omada Health, Optum Health, sanofi, and Zafgen. She has reported receiving research support from Dexcom, MannKind, and AstraZeneca, and serving as a member of a speakers bureau for Novo Nordisk. 

Miriam E. Tucker is a freelance journalist based in the Washington, DC, area. She is a regular contributor to Medscape, with other work appearing in the Washington Post, NPR’s Shots blog, and Diatribe. She is on X (formerly Twitter) @MiriamETucker. 

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/advisory-panel-votes-against-once-weekly-insulin-type-1-2024a10009we

Tags: advisoryhealthPanel
Previous Post

India heatwave news live: Akola hottest city in Maharashtra, Section 144 imposed

Next Post

Semaglutide Significantly Improves Chronic Kidney Disease

Midway’s Tate Mason named Week 7 WVLT Sports/5Star Preps Player of the Week – WVLT

Midway’s Tate Mason named Week 7 WVLT Sports/5Star Preps Player of the Week – WVLT

October 9, 2025
FIGO World Congress 2025 closes in Cape Town with renewed global commitment – FIGO.org

Global Leaders Unite in Cape Town to Close FIGO World Congress 2025 with Renewed Commitment

October 9, 2025
Our economic future is a black box – marketplace.org

Our economic future is a black box – marketplace.org

October 9, 2025
MSG Entertainment Takes Radio City Music Hall Into the Future With Introduction of Sphere Immersive Sound – Business Wire

MSG Entertainment Transforms Radio City Music Hall with Cutting-Edge Sphere Immersive Sound Experience

October 9, 2025
See photos from Pitt’s Health Sciences Alumni Weekend – University of Pittsburgh

See photos from Pitt’s Health Sciences Alumni Weekend – University of Pittsburgh

October 9, 2025
U.S. politics is broken because of MAGA Republicans and hard-line Democrats – AJC.com

How MAGA Republicans and Hard-Line Democrats Are Driving U.S. Politics to the Brink

October 9, 2025
Research team explores inclusion at conferences – EurekAlert!

Research team explores inclusion at conferences – EurekAlert!

October 9, 2025
If you feel you don’t really belong, here is some science-based advice – New Scientist

If you feel you don’t really belong, here is some science-based advice – New Scientist

October 9, 2025
Opinion | The most important Nobel prizes – The Washington Post

Opinion | The most important Nobel prizes – The Washington Post

October 9, 2025
Video: Owner Lists Shih Tzu’s ‘Toxic Traits’ & Internet Can’t Relate to It Enough – Yahoo

Watch: Owner Reveals Hilarious ‘Toxic Traits’ of Their Shih Tzu That Have Everyone Talking

October 9, 2025

Categories

Archives

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (859)
  • Economy (880)
  • Entertainment (21,753)
  • General (17,502)
  • Health (9,922)
  • Lifestyle (892)
  • News (22,149)
  • People (881)
  • Politics (890)
  • Science (16,090)
  • Sports (21,381)
  • Technology (15,860)
  • World (863)

Recent News

Midway’s Tate Mason named Week 7 WVLT Sports/5Star Preps Player of the Week – WVLT

Midway’s Tate Mason named Week 7 WVLT Sports/5Star Preps Player of the Week – WVLT

October 9, 2025
FIGO World Congress 2025 closes in Cape Town with renewed global commitment – FIGO.org

Global Leaders Unite in Cape Town to Close FIGO World Congress 2025 with Renewed Commitment

October 9, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version